ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 164 filers reported holding ARGENX SE in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $10,290,000 | +16.0% | 29,383 | 0.0% | 2.44% | +59.2% |
Q3 2021 | $8,874,000 | +0.3% | 29,383 | 0.0% | 1.53% | +2.0% |
Q2 2021 | $8,846,000 | -8.6% | 29,383 | -16.4% | 1.50% | -10.2% |
Q1 2021 | $9,675,000 | +18.6% | 35,132 | +26.6% | 1.67% | +32.1% |
Q4 2020 | $8,159,000 | -30.2% | 27,742 | -37.7% | 1.26% | -26.9% |
Q3 2020 | $11,695,000 | -54.8% | 44,550 | -61.2% | 1.73% | -59.2% |
Q2 2020 | $25,878,000 | +7.1% | 114,896 | -37.3% | 4.24% | +3.6% |
Q1 2020 | $24,157,000 | +90.3% | 183,384 | +131.9% | 4.09% | +64.2% |
Q4 2019 | $12,696,000 | – | 79,095 | – | 2.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |